Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kyowa Kirin Co's share price for the quarter that ended in Sep. 2023 was 円2604. Kyowa Kirin Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 538 Mil. Therefore, Kyowa Kirin Co's market cap for the quarter that ended in Sep. 2023 was 円1,399,936 Mil.
Kyowa Kirin Co's quarterly market cap
declined
from Mar. 2023 (円1,551,144 Mil) to Jun. 2023 (円1,432,185 Mil) and
declined
from Jun. 2023 (円1,432,185 Mil) to Sep. 2023 (円1,399,936 Mil).
Kyowa Kirin Co's annual market cap
increased
from Dec. 2020 (円1,511,613 Mil) to Dec. 2021 (円1,684,523 Mil) but then
declined
from Dec. 2021 (円1,684,523 Mil) to Dec. 2022 (円1,623,165 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kyowa Kirin Co's Enterprise Value for Today is 円1,052,037 Mil.
Kyowa Kirin Co Market Cap Historical Data
The historical data trend for Kyowa Kirin Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Kyowa Kirin Co's Market Cap
For the Drug Manufacturers - General subindustry, Kyowa Kirin Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kyowa Kirin Co's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kyowa Kirin Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Kyowa Kirin Co's Market Cap falls into.
Kyowa Kirin Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Kyowa Kirin Co's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kyowa Kirin Co (TSE:4151) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Kyowa Kirin Co Market Cap Related Terms
Thank you for viewing the detailed overview of Kyowa Kirin Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4151 has been successfully added to your 